🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 18 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/12/2000 31,38 31,63 30,50 30,81 -2,76% 3,59% 183.100
13/12/2000 31,14 32,25 30,94 31,69 -0,59% 4,21% 210.200
12/12/2000 31,75 32,00 30,50 31,88 -1,35% 4,72% 250.200
11/12/2000 30,25 32,50 28,75 32,31 +9,07% 12,40% 519.700
08/12/2000 29,61 30,88 28,56 29,63 +5,33% 7,81% 319.700
07/12/2000 28,28 29,00 25,50 28,13 -2,60% 12,38% 699.900
06/12/2000 32,13 32,63 28,44 28,88 -4,55% 13,04% 1.675.400
05/12/2000 30,50 30,63 29,25 30,25 +3,20% 4,51% 166.900
04/12/2000 31,31 31,38 29,31 29,31 -6,57% 6,59% 106.700
01/12/2000 28,88 31,44 28,88 31,38 +7,96% 8,87% 261.300
30/11/2000 30,00 30,02 28,50 29,06 -5,05% 5,05% 187.800
29/11/2000 33,81 34,00 30,00 30,61 -7,94% 11,83% 115.700
28/11/2000 34,75 35,31 32,63 33,25 -3,45% 7,73% 79.400
27/11/2000 33,13 35,38 33,00 34,44 +3,77% 7,17% 194.600
24/11/2000 32,83 33,19 32,75 33,19 +0,95% 1,33% 193.300
22/11/2000 31,88 33,50 31,88 32,88 -0,75% 5,10% 161.200
21/11/2000 35,59 35,59 32,00 33,13 -6,36% 10,10% 168.700
20/11/2000 36,39 36,63 34,00 35,38 -2,92% 7,21% 127.100
17/11/2000 36,91 37,44 35,75 36,44 +0,17% 4,57% 108.800
16/11/2000 36,02 38,75 36,00 36,38 -1,02% 7,64% 131.700
15/11/2000 36,00 37,81 35,00 36,75 +3,70% 7,81% 130.900
14/11/2000 34,98 36,13 34,88 35,44 +1,25% 3,57% 146.000
13/11/2000 39,00 39,44 31,38 35,00 -12,23% 20,67% 240.800
10/11/2000 38,25 40,00 37,50 39,88 -3,92% 6,54% 35.800
09/11/2000 37,00 41,75 37,00 41,50 +6,41% 12,84% 134.400
08/11/2000 42,11 43,69 39,00 39,00 -7,42% 11,13% 129.100
07/11/2000 42,13 43,50 41,75 42,13 -1,03% 4,15% 88.000
06/11/2000 43,19 44,88 42,50 42,56 +0,15% 5,50% 129.700
03/11/2000 40,97 42,94 40,27 42,50 +1,80% 6,52% 141.500
02/11/2000 37,55 41,88 37,50 41,75 +11,15% 11,65% 59.000